Germitec Honored at Premier, Inc.’s Annual Supplier Innovation Celebration

Ft. Myers, Florida and Bordeaux, France, September 22, 2026 – Germitec, a pioneering MedTech company specializing in UV-C High-Level Disinfection (HLD) for compatible ultrasound probes, today announced that it will be honored during Premier’s annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition. The Innovation Celebration recognizes groundbreaking healthcare technologies launched throughout the year and highlights how these products help improve the health of communities.

‍

“Premier’s recognition of Chronos^® validates what we have long believed: healthcare organizations should not have to choose between effective High-Level Disinfection and an efficient, sustainable workflow,” said Keith Koby, President North America of Germitec. “Chronos^® is designed to strengthen infection prevention while reducing the operational burden associated with traditional chemical-based processes.”

‍

Germitec Chronos^® is the first and only UV-C High-Level Disinfection (HLD) device to receive FDA De Novo marketing authorization, establishing the industry standard for all UV-C HLD technology that follows. Chronos^® powered by Yuvee^® delivers a 90-second¹, chemical-free disinfection cycle for compatible ultrasound probes, significantly reducing turnaround time between procedures and supporting greater patient throughput. By eliminating chemical disinfectants and consumables, Chronos^® removes a major recurring cost for health systems, driving meaningful savings across departments and facilities. Chronos^® is further supported by a landfill-free recycling program for aging chemical-based devices and an all-inclusive 5-year warranty, helping health systems advance sustainability goals alongside long-term operational savings.

‍

“Meaningful innovation must solve real challenges for the healthcare professionals and organizations adopting it,” said Peggy Day-Dvorak, Director of National and Government Accounts at Germitec. “We are honored that Premier has recognized Chronos^® as a technology with the potential to help health systems modernize their approach to High-Level Disinfection.”

‍

Chronos^® isn’t simply an incremental improvement, Chronos^® represents a significant advancement in High-Level Disinfection.

‍

Premier’s Innovation Celebration is entering its 15^th year of recognizing and honoring healthcare supplier innovation. More than 600 suppliers exhibit at the Breakthroughs Conference each year. Winners are selected by a national committee of clinicians, physicians and supply chain experts who evaluate each technology and its impact on patient care.  

‍

“Premier recognizes Germitec for its commitment to moving healthcare forward,” said Bruce Radcliff, President of Supply Chain Services at Premier. “Recognized at our 2026 Innovation Celebration, Germitec’s newest products and services reflect our shared mission to transform healthcare through improving efficiency, quality and patient outcomes. We are proud to work with Germitec and commend them for their continued innovation.”

‍

Premier is a leading technology-driven healthcare improvement company. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, advisory services and other solutions in service of our mission to improve the health of communities.

‍

 About Germitec

‍

Founded in 2005, Germitec is a French MedTech company specializing in UV-C High-Level Disinfection (HLD) for compatible ultrasound probes. Its Chronos^® system—FDA-cleared in 2024 for use in the US—delivers fast, chemical-free HLD at the point of care. Chronos^® provides full-chamber UV-C coverage for both endocavitary (transvaginal, transrectal) and external devices, reducing equipment wear, eliminating chemical use and associated costs, and maintaining audit readiness through automated digital documentation. Germitec’s breakthrough technologies have a proven record of safety and efficacy and are used across more than 40 countries globally. For more information, visit www.germitec.com.

‍

1. Germitec internal data: average cycle time of 90 seconds
*Chronos^® is not indicated for ultrasound probes that contain lumens and/or indentations or channels that are deeper than their widths.

‍

‍